Skip to main content
Log in

D-Amphetamine in obsessive-compulsive disorder

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In a double-blind rossover study, single doses of d-amphetamine and placebo were administered to 12 patients with severe chronic obsessive-compulsive disorder (OCD). Improvement of obsessional symptoms was significant on clinical ratings and was correlated with improved performance on an attention task. Changes were also significant for self-rated measures of activation and altered reality. The behavioral response to amphetamine was not statistically correlated with subsequent improvement during a 6-week clomipramine trial, although the direction of change was the same during both treatments for every patient studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altschuler M (1962) Massive doses of trifluoperazine in the treatment of compulsive rituals. Am J Psychiatry 119:367

    Google Scholar 

  • Ananth J (1976) Treatment of obsessive compulsive neurosis: Pharmacological approach. Psychosomatics 17:180–184

    Google Scholar 

  • Brown WA, Corriveau DP, Ebert MH (1978) Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology 58:189–195

    Google Scholar 

  • DelRio J, Fuentes JA (1969) Further studies on the antagonism of stereotyped behavior induced by amphetamine. Eur J Pharmacol 8:73–78

    Google Scholar 

  • Ebert M, Van Kammen DP, Murphy DL (1976) Plasma levels of amphetamine and behavioral response: In: Gottschalk L (ed) Pharmacokinetics of psychoactive drugs: Blood levels and clinical response. Spectrum, New York, pp 157–169

    Google Scholar 

  • Ellinwood EH Jr (1967) Amphetamine psychosis. I. Description of the individuals and process. J Nerv Ment Dis 144:273–283

    Google Scholar 

  • Frye PE, Arnold LE (1981) Persistent amphetamine-induced compulsive rituals: Response to pyridoxine (B6). Biol Psychiatry 16:583–587

    Google Scholar 

  • Fawcett J, Siomopoulos V (1971) Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression. Arch Gen Psychiatry 25:247–255

    Google Scholar 

  • Hussain MZ, Assad I (1970) A treatment of obsessive-compulsive neurosis (letter). Can Med Assoc J 103:648–650

    Google Scholar 

  • Insel TR (1982) Obsessive compulsive disorder: Five clinical questions and a suggested approach. Comp Psychiatry 23:241–251

    Google Scholar 

  • Insel TR, Murphy DL (1981) The psychopharmacologic treatment of obsessive compulsive disorder: A review. J Clin Psychopharmacol 1:304–311

    Google Scholar 

  • Insel TR, Alterman I, Murphy DL (1982) Antidepressant and antiobsessional effects with clomipramine. Psychopharmacol Bull 18: 315–319

    Google Scholar 

  • Insel TR, Murphy DL, Cohen RM, Alterman I, Linnoila M, Kilts C (1983) Obsessive-compulsive disorder: A double-blind treatment study of clomipramine and clorgyline. Arch Gen Psychiatry (in press)

  • Jelliffe SE (1927) Postencephalitic respiratory disorders. Nervous and Mental Disease Publications, New York

    Google Scholar 

  • Marks IM, Stern R, Mawson D, Cobb J, McDonald R (1980) Clomipramine and exposure for obsessive-compulsive rituals. Br J Psychiatry 36:1–25

    Google Scholar 

  • Meldman MJ (1970) Diseases of attention and perception. Pergamon, New York

    Google Scholar 

  • Murphy DL, Pickar D, Alterman IS (1982) Methods for the quantitative assessment of depressive and manic behavior. In: Burdock EI, Sudilovsky A, Gershon S (eds) The behavior of psychiatric patients. Marcel Dekker, New York, pp 355–392

    Google Scholar 

  • Nurnberger JI, Gershon ES, Simmons S, Ebert M, Kessler LR, Dibble E, Jimerson SS, Brown GM, Gold P, Jimerson DC, Guroff JJ, Storch FI (1982) Behavioral, biochemical, and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients. Psychoneuroendocrinology 7:163–176

    Google Scholar 

  • Post RM, Gerner RH, Carman JS, Gillin JC, Jimerson DC, Goodwin Fk, Bunney WE Jr (1978) Effects of a dopamine agonist piribedil in depressed patients. Arch Gen Psychiatry 35:609–615

    Google Scholar 

  • Randrup A, Munkvad I (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11:300–310

    Google Scholar 

  • Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309–314

    Google Scholar 

  • Rapoport J, Elkins R, Mikkelsen E, Lipsky A (1980) Clinical controlled trial of chlorimipramine in adolescents with obsessive-compulsive disorder. Psychopharmacol Bull 16:61–63

    Google Scholar 

  • Ridley RM, Baker HF, Haystead TAJ (1981) Perseverative behavior after amphetamine: Dissociation of response tendency from reward association. Psychopharmacology 75:283–286

    Google Scholar 

  • Rosvold HE, Mirsky AF, Sarason I, Brunsome E, Beck L (1956) A continuous performance test of brain damage. J Consult Psychol 20:343–350

    Google Scholar 

  • Schilder P (1938) The organic background of obsessions and compulsions. Am J Psychiatry 94:1397–1430

    Google Scholar 

  • Schiörring E (1975) Changes in individual and social behavior induced by amphetamine and related compounds in monkeys and man. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Plenum, New York, pp 481–516

    Google Scholar 

  • Silberman EK, Reus VI, Jimerson DC, Lynott AM, Post R (1981) Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry 138:1302–1307

    Google Scholar 

  • Tecce JJ, Cole JO (1974) Amphetamine effects in man: Paradoxical drowsiness and lowered electrical brain activity (CNV). Science 185:451–455

    Google Scholar 

  • Thoren P, Åsberg M, Cronholm B, Jörnestedt L, Träskman L (1980) Clomipramine treatment of obsessive compulsive disorder: A controlled clinical trial. Arch Gen Psychiatry 37:1281–1289

    Google Scholar 

  • Van Kammen DP, Murphy DL (1978) Prediction of imipramine antidepressant response by a 1-day d-amphetamine trial. Am J Psychiatry 135:1179–1183

    Google Scholar 

  • Van Kammen DP, Murphy DL (1979) Prediction of antidepressant response to lithium carbonate by a 1-day administration of d-amphetamine in unipolar depressed women. Neuropsychobiology 5:266–273

    Google Scholar 

  • Van Kammen DP, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215–224

    Google Scholar 

  • Van Kammen DP, Bunney WE Jr, Docherty JP, Murder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982) d-Amphetamine induces heterogeneous changes in psychotic behavior. Am J Psychiatry 139:991–997

    Google Scholar 

  • Wallach MB (1974) Drug-induced stereotyped behavior. In: Usdin E (ed) Neuropsychopharmacology of monoamines and their regulatory enzymes. Raven, New York, pp 241–260

    Google Scholar 

  • Wallach MB, Gershon S (1972) The induction and antagonism of central nervous system stimulant induced stereotyped behavior in the cat. Eur J Pharmacol 18:22–26

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Insel, T.R., Hamilton, J.A., Guttmacher, L.B. et al. D-Amphetamine in obsessive-compulsive disorder. Psychopharmacology 80, 231–235 (1983). https://doi.org/10.1007/BF00436159

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00436159

Key words

Navigation